The ratio of ADSCs to HSC‑progenitors in adipose tissue derived SVF may provide the key to predict the outcome of stem‑cell therapy - San Francisco Stem Cell Treatment Center

The ratio of ADSCs to HSC‑progenitors in adipose tissue derived SVF may provide the key to predict the outcome of stem‑cell therapy

Background: Stromal vascular fraction (SVF) represents an attractive source of adult stem cells and progenitors, holding great promise for numerous cell therapy approaches. In 2017, it was reported that 1524 patients received autologous SVF following the enzymatic digestion of liposuction fat. The treatment was safe and effective and patients showed significant clinical improvement. In a collaborative study, we analyzed SVF obtained from 58 patients having degenerative, inflammatory, autoimmune diseases, and advanced stage cancer.

Click here to download PDF of the full study

San Francisco Stem Cell Treatment Center

Subscribe To Our Newsletter

Join our mailing list to receive the latest news and updates from our team.

Thank you for your interest in the San Francisco Stem Cell Treatment Center. You have been added to our list.